(Q35817165)

10 August 2017

1 reference

title

Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder (English)

1 reference

10 August 2017

Badrinath R Konety

1

1 reference

PubMed ID

15217424

10 August 2017

Richard D Williams

series ordinal

2

1 reference

10 August 2017

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

94

1 reference

10 August 2017

18-21

1 reference

10 August 2017

1

1 reference

Urine based markers of urological malignancy

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

Adherence to Surveillance Among Patients With Superficial Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

Optimal treatment of systemic bacillus Calmette-Guérin infection: investigations in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2003.04894.X

10.1111/J.1464-410X.2003.04894.X

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15217424